Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 21) Stocks In Focus Aurinia Announces FDA Acceptance of NDA For Kidney Inflammation Drug With Priority Review Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) said the FDA has accepted the filing of its NDA for voclosporin, as a potential treatment for lupus nephritis, a serious inflammation of the kidneys caused by the autoimmune disease systemic lupus erythematosus.FDA To Hold an Adcom Review of Mesoblast's BLA For Acute GvHD Drug Mesoblast limited (NASDAQ: MESO) said the Oncologic Drugs Advisory Committee of the FDA has scheduled a meeting Aug. 13 to review data supporting its BLA for the approval of Ryoncil for the treatment of steroid-refractory acute graft versus host disease in children.